Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$6.10+0.22 (+3.74%)
Close on Nov 13, 2026Market cap $114.13MP/E –Yield –
Trinity Biotech ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$15.54M. The highest annual figure on record is $41.94M in fiscal 2021.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.54M | – |
| FY2024 | Dec 31, 2024 | -$20.96M | – |
| FY2023 | Dec 31, 2023 | -$27.05M | – |
| FY2022 | Dec 31, 2022 | -$19.35M | -146.1% |
| FY2021 | Dec 31, 2021 | $41.94M | +34275.4% |
| FY2020 | Dec 31, 2020 | $122.00K | – |
| FY2019 | Dec 31, 2019 | -$24.11M | – |
| FY2018 | Dec 31, 2018 | -$20.15M | – |
| FY2017 | Dec 31, 2017 | -$37.14M | – |
| FY2016 | Dec 31, 2016 | -$39.43M | -390.5% |
| FY2015 | Dec 31, 2015 | $13.57M | – |
See a number that looks wrong?